BCM
OMIC

Bridgeway Capital Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bridgeway Capital Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,050
Closed -$62.5K – 1362
2024
Q1 		$62.5K Hold
4,050
– – ﹤0.01% 1253
2023
Q4 		$55.9K Sell
4,050
-5,200
-56% -$61.5K ﹤0.01% 1302
2023
Q3 		$106K Hold
9,250
– – ﹤0.01% 1221
2023
Q2 		$230K Buy
9,250
+1,770
+24% +$51.9K 0.01% 1101
2023
Q1 		$272K Sell
7,480
-103
-1% -$6.31K 0.01% 1045
2022
Q4 		$457K Buy
7,583
+7,186
+1,810% +$482K 0.01% 907
2022
Q3 		$30K Sell
397
-53
-12% -$5.54K ﹤0.01% 1375
2022
Q2 		$52K Buy
+450
New +$52.8K ﹤0.01% 1279

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bridgeway Capital Management's OMIC Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 4,050 shares — an estimated $62.5K sold.

Bridgeway Capital Management first reported a position in OMIC in Q2 2022 and held it in 8 quarters. The position peaked at $457K in Q4 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Bridgeway Capital Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 4,050 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $62.5K.
  • Bridgeway Capital Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Bridgeway Capital Management's Singular Genomics Systems, Inc. Common Stock position peaked at $457K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.